Joseph Shaw profile picture

Contact Information

Joseph Shaw, MD, FRCPC

josshaw@toh.ca

www.linkedin.com/in/josephrshaw



ORCID logo https://orcid.org/0000-0002-2405-7912

Publications

Selected Publications

1. Shaw JR., Castellucci LA., Siegal D., Carrier M. (2023). DOAC-associated bleeding, hemostatic strategies and thrombin generation assays - a review of the literature. J Thromb Haemost. 2022 Dec 22;S1538-7836(22)07643-7. doi: 10.1016/j.jtha.2022.11.029. Online ahead of print

2.
Aziz J., Wang TF., Siegal D., Douketis J., Le Gal G., Carrier M., Shaw JR. (2022). Thrombotic and bleeding outcomes following the perioperative interruption of anticoagulation among patients with nonvalvular atrial fibrillation and active cancer. 2022 Dec 27;S1538-7836(22)18255-3. doi: 10.1016/j.jtha.2022.12.016. Online ahead of print.

3. Shaw JR.
, Li N., Nixon J., Moffat KA., Spyropoulos AC., Schulman S., Douketis JD. (2022). Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedure. J Thromb Haemost;
20(12): 2953-2963
 
4. Shaw JR., Kumar V., Mallick R., Carrier M., Ilich A., Key N., Wells P. (2020) Biomarker-enhanced VTE risk stratification in ambulatory patients with cancer. Thromb Res; 196: 437-443

5. Shaw JR., Li N., Vanassche T., Coppens M., Spyropoulos A.C., Syed S., Radwi M., Duncan J., Schulman S., Douketis J. (2020) Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure. Blood Advances; 4(15): 3520-3527

6. Shaw JR., Kaplovitch E., Douketis J. (2020) Periprocedural management of oral anticoagulation. Med Clin North Am; 104(4): 709-726

7. Shaw JR., Carrier M, Dowlatshahi D, Chakraborty S, Tokessy M, Buyukdere H, Castellucci LA (2020). Activated prothrombin complex concentrates for direct oral anticoagulant-associated bleeding or urgent surgery: Hemostatic and thrombotic outcomes. Thromb Res;195: 21-28.

8. Shaw JR., Siegal D.M. (2020). Prothrombin complex concentrates for DOAC-associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact? Res Pract Thromb Haemost; 4(5): 677-679

9. Shaw JR., Douketis J., Le Gal G., Carrier M (2019). Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes. J Thromb Haemost; 17(7): 1171-1178

10. Shaw JR., Siegal D.M. (2018). Pharmacological reversal of the direct oral anticoagulants – A comprehensive review of the literature. Res Pract Thromb Haemost; 2:251-265